Back

Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction

27 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Kristina Kopeva

Cardiology Research Institute, Tomsk NRMC, Tomsk (Russian Federation)

21 More presentations in this session

Presentation thumbnail
Associate Professor H. Fukuta (Nagoya, JP)
Abstract
Presentation thumbnail
Doctor Q. Wang (Lanzhou, CN)
Abstract
Presentation thumbnail
Associate Professor M. Marketou (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Doctor M. Kurkina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Professor R. Shoucri (Kingston, CA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

27 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources